🟢 LifeMD is trading 10.16% up today with no clear catalyst identified

LifeMD is trading 10.16% up now at $3.36, with no clear company-specific catalyst identified.

• No company-specific announcement, filing, earnings update, or analyst action dated September 14, 2026 was identified.
• B. Riley reaffirmed its Buy rating on September 11 with an approximately $8 price target, providing positive background but not establishing today’s direct catalyst.
• Healthcare is outperforming broader markets, supporting a possible sector-rotation explanation, though the unusually large gain remains partly unexplained.